Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
RS needs to pass through FINRA?
What if not accepted?
1.04B -> 1.5B?
Common Shares
1,500,000,000
Common Par Value
$0.0001
Preferred Shares
5,000,000
Preferred Par Value
$0.0001
They almost mentioned NVDA partnership everyday in their tweets. If you have no idea on my question context, that meant you don’t read their tweets. Then how you can answer my question? Your guess is same as mine.
They have another tweet today that may provide more hints!
Apparently you missed many updates. Go to the company twitter account and see their posts.
They are now touting out $4 pps down the road…it is crazy given that ask is still at T2
Anyone read their tweet about partnership with Nvidia? It is more like QHP just used NVDA AI chips or hardware in their energy service platform, right?
I use MS Office or Amazon WS in my startup, can I say partnership with Microsoft or Amazon?
Report him to SEC
Where he said that? Link pls
Link please
52 week low tomorrow?
Why investing in blockchain technology? It has been there for many years already. Why not AI? EV?
Crypto mining is banned in China. So why the Chinese government is behind this surge? It is illegal for them!!
HT$C, the largest shareholder with 2.2 billion shares, has a subsidiary Fortune Nickel & Gold. David Beling serves as a strategic advisor there. They want to position themselves as nickel supplier in the EV battery supply chain. Looks like big thing coming if all lined up in good shape.
Something interesting if it is real….
Attention $IDGC shareholders: Company management has arranged an amazing opportunity to close our Asians partners on a large quantity of #EVNanocell #batteries. We just arranged for large money raiser David Beling PEG. to l become a large capital funder & Strategic Advisor. $AI
Why CUSIP change?
Applied UV, Inc. (AUVI) performed a 1:1 CUSIP change.
How the company does the announced RS given two failed prior attempts to get approval from FINRA? The company could not provide the doc FINRA requested.
The fact is, no 2500:1 RS if no approval from FINRA
Added more and will add more for new low.
It looks like a good news to shareholders, right?
“On August 1, 2023, Datasea Inc. (the “Company”) entered into two separate subscription agreements (the “Agreements”) with a certain non-U.S. investor (the “Investor”), pursuant to which the Company agreed to sell and the Investor agreed to purchase an aggregate of 4,760,000 shares of common stock price (the “Shares”) at a $1.2 per share purchase price. The Investor understands that the Shares must be held for a period of 365 days. In accordance with the two Agreements, the Investor shall pay a total purchase price of $2,856,000 in RMB, with an amount of ¥ 20,000,000 no later than September 10, 2023 and another purchase price of $2,856,000 in RMB, with an amount of ¥ 20,000,000 no later than September 30, 2023.”
What is going on AH? CH11 filing tomorrow?
But hold and wait does not work in otc stocks. People usually has no patience and they will dump when they see other opportunities. I bet it will fall back to 000x
The pr has no meat, just some admin statements!
Did you ask what information the company cannot provide?
FINRA does not really do approval on RS (a corporate action) but process the request according to the FINRA Rule 6490 which requires issuers to complete and file a document with FINRA at least 10 business days prior to the record date of the corporate action.
FINRA approval must be received prior to the corporate action becoming effective. In addition, FINRA may request additional documents, conduct detailed and selective reviews of the issuer submissions and cause the issuer to delay the announcement of its corporate action.
A FINRA review will be triggered if any of the five factors set forth in Rule 6490 are thought to be present:
1) FINRA believes the forms are incomplete, inaccurate or filed without the appropriate corporate authority;
2) The issuer is not current in its reporting obligations with the Securities and Exchange Commission;
3) Persons involved in or related to the corporate action are the subject of pending or settled regulatory action or are under investigation by a regulatory body or are the subject of a pending criminal action related to fraud or securities law violations;
4) Persons related to the corporate action are likely involved in fraudulent activities involving securities or may pose a threat to investors; and
5) There is significant uncertainty in the settlement and clearance process for the issuer’s securities.
I think their filing mentioned they were requested to provide additional information regarding the RS and name change, so probably fall under the first category above but it seems no one know what exactly it was about!
The new company has $54M cash after the merger and can pay back the $1.4M debt easily. Remember there is obligation that upon closing, the debts of the old company will be transferred to the new company along with the balance sheets.
So what is the point to do the RS before the merge?
News or tweet?
Is it pump and dump? Done?
No t trades in the last 3 sessions is a good sign
Hope the seller will not be regret in future
0.005 close?
May see penny very soon
Management could remove the RS message anytime now as it is irrelevant in the merger. That could help boost up the pps before the merger officially closed
The acquisition news on 5/30 only showed up under RWOD
————
Upon completion of the transaction, the combined company will operate as ANEW MEDICAL and expects to remain listed on NASDAQ.
ANEW is dedicated to realizing the potential of gene therapies to offer transformative patient outcomes in areas of high unmet medical need and extending the reach of gene therapies to highly prevalent neurodegenerative disorders. The Company has assembled a portfolio of gene therapies in partnership with leading scientific institutions and has built a core team with extensive experience in the gene therapy, drug development, and commercialization space. ANEW is initially focused on progressing programs that include alpha Klotho-based gene therapies for ALS, Alzheimer's disease, and Parkinson's disease.
Based on the 1B OS?
Is the final company under otc or nasdaq?
Let’s see if it can bounce back to 2.2
Buyout coming?
The 8K does not seem anything significant, likely it will be shorted back down to lower next week
Have you checked norcelli.com? Nothing mentioned there about the relationship with IDGC.
Why selling shares almost at all time low? Probably debt conversion or dilution
Got the ticket yet? Miracle is coming…..
Time to get some tickets…maybe one day miracle happens…lol
Hit 0.001 today?